[HTML][HTML] Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation

E Imbalzano, G Murdaca, L Orlando… - International Journal of …, 2022 - mdpi.com
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …

Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation

E Imbalzano, G Murdaca, L Orlando, GD Fazio… - INTERNATIONAL …, 2022 - iris.unime.it
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …

Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation

E Imbalzano, G Murdaca, L Orlando… - 2022 - agris.fao.org
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …

[HTML][HTML] Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation

E Imbalzano, G Murdaca, L Orlando… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …

Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation.

E Imbalzano, G Murdaca, L Orlando… - International …, 2022 - search.ebscohost.com
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …

Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation.

E Imbalzano, G Murdaca, L Orlando… - … Journal of Molecular …, 2022 - europepmc.org
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …

Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation

E Imbalzano, G Murdaca, L Orlando… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …

Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation

E Imbalzano, G Murdaca, L Orlando… - International …, 2022 - search.proquest.com
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …

[引用][C] Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation

E Imbalzano, G Murdaca, L Orlando… - Int. J. Mol. Sci, 2022 - europepmc.org
To date, worldwide, atrial fibrillation is the most common cardiovascular disease in adults,
with a prevalence of 2% to 4%. The trigger of the pathophysiological mechanism of …